Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhongxin Feng

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Experimental and Therapeutic Medicine|February 28, 2020
Raised CD40L expression attenuates drug resistance in Adriamycin-resistant THP-1 cellsZhongxin Feng, Qi Chen
Oncology Letters|December 7, 2020
Soluble CD40 ligand inhibits the growth of non-Hodgkin's lymphoma cells through the JNK signaling pathwayZhongxin Feng, Jishi Wang
Oncotargets and Therapy|May 23, 2019
CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathwayZhongxin Feng, Qi Chen, Mingqiang Ren, et al.
American Journal of Cancer Research|December 9, 2020
Clonal expansion of bone marrow CD8<sup>+</sup> T cells in acute myeloid leukemia patients at new diagnosis and after chemotherapyZhongxin Feng, Qin Fang, Xingyi Kuang, et al.
American Journal of Cancer Research|December 7, 2021
Increased lactate in AML blasts upregulates TOX expression, leading to exhaustion of CD8<sup>+</sup> cytolytic T cellsYing Chen, Zhongxin Feng, Xingyi Kuang, et al.
Biomed Research International|March 19, 2019
Functional Variant rs4442975 Modulating FOXA1 Binding Affinity Can Influence Bone Marrow Suppression during Neoadjuvant Chemotherapy for Luminal A Type Breast CancerXin Wang, Zhongxin Feng, Juan Li, et al.
Biosensors & Bioelectronics|February 29, 2024
A highly integrated digital PCR system with on-chip heating for accurate DNA quantitative analysisKang Peng, Zhihong Wu, Zhongxin Feng, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Experimental and Therapeutic Medicine|February 28, 2020
Raised CD40L expression attenuates drug resistance in Adriamycin-resistant THP-1 cellsZhongxin Feng, Qi Chen
Oncology Letters|December 7, 2020
Soluble CD40 ligand inhibits the growth of non-Hodgkin's lymphoma cells through the JNK signaling pathwayZhongxin Feng, Jishi Wang
Oncotargets and Therapy|May 23, 2019
CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathwayZhongxin Feng, Qi Chen, Mingqiang Ren, et al.
American Journal of Cancer Research|December 9, 2020
Clonal expansion of bone marrow CD8<sup>+</sup> T cells in acute myeloid leukemia patients at new diagnosis and after chemotherapyZhongxin Feng, Qin Fang, Xingyi Kuang, et al.
American Journal of Cancer Research|December 7, 2021
Increased lactate in AML blasts upregulates TOX expression, leading to exhaustion of CD8<sup>+</sup> cytolytic T cellsYing Chen, Zhongxin Feng, Xingyi Kuang, et al.
Biomed Research International|March 19, 2019
Functional Variant rs4442975 Modulating FOXA1 Binding Affinity Can Influence Bone Marrow Suppression during Neoadjuvant Chemotherapy for Luminal A Type Breast CancerXin Wang, Zhongxin Feng, Juan Li, et al.
Biosensors & Bioelectronics|February 29, 2024
A highly integrated digital PCR system with on-chip heating for accurate DNA quantitative analysisKang Peng, Zhihong Wu, Zhongxin Feng, et al.
Pageof 1